BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29402406)

  • 1. Secretion of GLP-1 but not GIP is potently stimulated by luminal d-Allulose (d-Psicose) in rats.
    Hayakawa M; Hira T; Nakamura M; Iida T; Kishimoto Y; Hara H
    Biochem Biophys Res Commun; 2018 Feb; ():. PubMed ID: 29402406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canagliflozin potentiates GLP-1 secretion and lowers the peak of GIP secretion in rats fed a high-fat high-sucrose diet.
    Hira T; Koga T; Sasaki K; Hara H
    Biochem Biophys Res Commun; 2017 Oct; 492(2):161-165. PubMed ID: 28803984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of D-allulose and Erythritol on the Activity of the Gut Sweet Taste Receptor and Gastrointestinal Satiation Hormone Release in Humans: A Randomized, Controlled Trial.
    Teysseire F; Bordier V; Budzinska A; Weltens N; Rehfeld JF; Holst JJ; Hartmann B; Beglinger C; Van Oudenhove L; Wölnerhanssen BK; Meyer-Gerspach AC
    J Nutr; 2022 May; 152(5):1228-1238. PubMed ID: 35135006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sweet Taste Receptor Activation in the Gut Is of Limited Importance for Glucose-Stimulated GLP-1 and GIP Secretion.
    Saltiel MY; Kuhre RE; Christiansen CB; Eliasen R; Conde-Frieboes KW; Rosenkilde MM; Holst JJ
    Nutrients; 2017 Apr; 9(4):. PubMed ID: 28441725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose.
    Iwasaki Y; Sendo M; Dezaki K; Hira T; Sato T; Nakata M; Goswami C; Aoki R; Arai T; Kumari P; Hayakawa M; Masuda C; Okada T; Hara H; Drucker DJ; Yamada Y; Tokuda M; Yada T
    Nat Commun; 2018 Jan; 9(1):113. PubMed ID: 29317623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of corn zein hydrolysate stimulates GLP-1 and GIP secretion and improves glucose tolerance in male normal rats and Goto-Kakizaki rats.
    Higuchi N; Hira T; Yamada N; Hara H
    Endocrinology; 2013 Sep; 154(9):3089-98. PubMed ID: 23798598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
    Pacini G; Thomaseth K; Ahrén B
    Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves.
    Mayer F; Gunawan AL; Tso P; Aponte GW
    Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G23-G35. PubMed ID: 32421358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update.
    Nauck MA; Quast DR; Wefers J; Pfeiffer AFH
    Diabetes Obes Metab; 2021 Sep; 23 Suppl 3():5-29. PubMed ID: 34310013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incretin hormones and type 2 diabetes.
    Nauck MA; Müller TD
    Diabetologia; 2023 Oct; 66(10):1780-1795. PubMed ID: 37430117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 secretion in humans: Characteristics and regulation.
    Alsalim W; Lindgren O; Ahrén B
    J Diabetes Investig; 2023 Mar; 14(3):354-361. PubMed ID: 36539382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice.
    Moriya R; Shirakura T; Ito J; Mashiko S; Seo T
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1358-65. PubMed ID: 19808907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop.
    Roberge JN; Brubaker PL
    Endocrinology; 1993 Jul; 133(1):233-40. PubMed ID: 8319572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats.
    Wang JH; Inoue T; Higashiyama M; Guth PH; Engel E; Kaunitz JD; Akiba Y
    J Pharmacol Exp Ther; 2011 Nov; 339(2):464-73. PubMed ID: 21846840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Insulin Response to Oral Glucose in GIP and GLP-1 Receptor Knockout Mice: Review of the Literature and Stepwise Glucose Dose Response Studies in Female Mice.
    Ahrén B; Yamada Y; Seino Y
    Front Endocrinol (Lausanne); 2021; 12():665537. PubMed ID: 34122340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects.
    Elahi D; McAloon-Dyke M; Fukagawa NK; Meneilly GS; Sclater AL; Minaker KL; Habener JF; Andersen DK
    Regul Pept; 1994 Apr; 51(1):63-74. PubMed ID: 8036284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate-induced secretion of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1.
    Seino Y; Maekawa R; Ogata H; Hayashi Y
    J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):27-32. PubMed ID: 27186352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of incretin secretion by dietary lipid: is it dose dependent?
    Yoder SM; Yang Q; Kindel TL; Tso P
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G299-305. PubMed ID: 19520739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men.
    Matikainen N; Söderlund S; Björnson E; Bogl LH; Pietiläinen KH; Hakkarainen A; Lundbom N; Eliasson B; Räsänen SM; Rivellese A; Patti L; Prinster A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
    Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):534-542. PubMed ID: 28428027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.